Rainbow Coral to hunt for new innovations, potential partnerships at Biotech Showcase

Executive leadership from Rainbow Coral Corp. (OTCBB: RBCC), a fast-rising biotechnology company, will scout for new innovations and potential partnerships this month at the sixth annual Biotech Showcase in San Francisco.

Held January 13-15, the Biotech Showcase investor and partnering conference is an established innovation forum for life science investors. Executive-level delegates representing top public and private investment firms come with the single aim to partner with emerging biotechnology and life science companies.

It's an ideal place for RBCC executives to meet and hear from cutting-edge researchers and developers who could potentially help the company achieve its ambitious goals in the booming global drug delivery and personalized medicine markets.

"There's no more important industry showcase in the U.S.," said RBCC CEO Kimberly Palmer. "It's the largest gathering of leading-edge, growth-oriented biotech innovation in the country, and we're tremendously excited to make new contacts and, potentially, new partnerships at the conference that could help make 2014 our best year yet."

By acquiring or partnering with up-and-coming biotech innovators, RBCC plans to be well-positioned to capitalize on the big growth in store for the industry. The company invests in new technology developed to compete in the biotechnology sector alongside Amgen (NASDAQ: AMGN), Dendreon Corporation (NASDAQ: DNDN), Smith & Nephew (NYSE: SNN) and Pharmaceutical Product Development (NASDAQ: PPDI).

Source: Rainbow Coral Corp.